High velocity nasal insufflation versus non-invasive ventilation in acute respiratory failure: a comparative study

Author:

Abd El Aziz Aml A1,Abdelaal Gehan A1,Gasad Heba R1,Tawadros Bishoy B1

Affiliation:

1. Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Menoufia University, Menoufia, Egypt

Abstract

Background In order to treat respiratory failure, thermo-humidified nasal high flow oxygen (NHFO) therapy is being used more and more. In several clinical scenarios, NHFO has recently gained popularity as alternative noninvasive respiratory ventilation. Aim The aim is to assess the role of high velocity nasal insufflation (HVNI) versus noninvasive ventilation (NIV) in acute respiratory failure. Patients and methods This is a prospective randomized clinical study conducted on 60 patients admitted to the Chest Department at Menoufia University Hospital with acute respiratory failure. Patients were randomized to receive either noninvasive positive pressure ventilation using an oronasal mask or high-velocity nasal insufflation (initial flow was at 30-40 l/min; temperature was adjusted to 37°C; fraction of inspired oxygen 1.0) with clinical monitoring and arterial blood gas (ABG) monitoring after 2, 6, 12, and 24 h. Results The therapeutic impact of both, HVNI and NIV, on pressure of arterial carbon dioxide (PaCO2), hydrogen ion concentration, arterial oxygen saturation and pressure of arterial oxygen (PaO2) over time was almost similar. There was an improvement in dyspnea and a decrease in respiratory rate over time when compared with baseline results in both groups. There was no statistical difference between both groups. The failure rate in type I respiratory failure (RF) was 33.3% in the HVNI group and 28.6% in the NIV group (P-value 0.7). The failure rate in type II RF was 41.7% in the HVNI group and 25% in the NIV group (P-value 0.3). HVNI was more comfortable for patients and provided better communication and oral intake. Conclusion This study demonstrates that the HVNI was comparable to the NIV in the management of hypoxemic respiratory failure and could be used as a noninvasive method of ventilation alternative to the BiPAP in hypercapnic RF, with more comfortability and better communication in the HVNI group.

Publisher

Medknow

Reference13 articles.

1. High flow through nasal cannula in exacerbated COPD patients: a systematic review;Pisani;Pulmonology,2019

2. High-flow nasal oxygen therapy in intensive care and anaesthesia;Renda;Br J Anaesth,2018

3. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model;Frizzola;Pediatr Pulmonol,2011

4. Computational fluid dynamics modeling of extrathoracic airway flush: evaluation of high flow nasal cannula design elements;Miller;J Pulmon Respir Med,2016

5. Assessment of high flow nasal cannula therapy use in the emergency department setting: observations of practice across four systems;Spivey;Respir Ther,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3